首页> 美国卫生研究院文献>Molecules >Synthesis and In Vitro Evaluation of Caffeoylquinic Acid Derivatives as Potential Hypolipidemic Agents
【2h】

Synthesis and In Vitro Evaluation of Caffeoylquinic Acid Derivatives as Potential Hypolipidemic Agents

机译:咖啡酰奎尼酸衍生物作为潜在的降血脂药的合成及体外评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of novel caffeoylquinic acid derivatives of chlorogenic acid have been designed and synthesized. Biological evaluation indicated that several synthesized derivatives exhibited moderate to good lipid-lowering effects on oleic acid-elicited lipid accumulation in HepG2 liver cells. Particularly, derivatives >3d, >3g, >4c and >4d exhibited more potential lipid-lowering effect than the positive control simvastatin and chlorogenic acid. Further studies on the mechanism of >3d, >3g, >4c and >4d revealed that the lipid-lowering effects were related to their regulation of TG levels and merit further investigation.
机译:设计并合成了一系列新型的绿原酸咖啡酰奎尼酸衍生物。生物学评估表明,几种合成衍生物对HepG2肝细胞中油酸引起的脂质蓄积具有中等至良好的降脂作用。特别地,与阳性对照辛伐他汀相比,衍生物> 3d ,> 3g ,> 4c 和> 4d 具有更大的潜在降脂作用。和绿原酸。对> 3d ,> 3g ,> 4c 和> 4d 机理的进一步研究表明,降脂作用与他们对TG水平的调控,值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号